Novartis AG Overview
Valuation check: NVS's P/E ratio is 23.57, below the Healthcare sector average of 77.98.
Get informed when a big investor buys or sells
+ Follow23.57
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, NVS shows a P/E ratio of 23.57. That is below the Healthcare sector average of 77.98. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 77.98. Novartis AG is at 23.57, which is lower that average. That is roughly 69.8% below the sector mean. Use the comparison chart on this page to see how NVS stacks up against individual peers as well.
Investors watch NVS's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Novartis AG's latest reading is 23.57. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Novartis AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 23.57) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 77.98, while NVS is at 23.57. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
